Pharmaceuticals, Biotechnology and Life Sciences
Inflammasome Therapeutics is entitled to receive up to $160 million in milestone and gated development payments as well as tiered royalties and other milestones due on commercialization.
Read more
USAFDA has given approvals for Merck’s Pifeltro and Delstrigo for certain HIV-1 patients, based on fFindings from the Phase 3 DRIVE-SHIFT Trial, Merck said on Friday in a press release.
Read more
European Commission will in about two months decide on the Committee for Medicinal Products for Human Use’s positive opinion, recommending approval of Rhokiinsa in EU, developed by Aerie Pharmaceuticals, for reduction of elevated intraocular pressure in adult patients.
Read moreLOS ANGELES–(BUSINESS WIRE)–#biomarkers–In promoting Andrew Aijian to Partner, DeciBio Consulting announces its first addition to the Partnership since its formation.
Read moreSTRASBOURG, France–(BUSINESS WIRE)–#Defymed—Medical technology company Defymed, specialized in the design and development of innovative medical devices for the delivery
Read moreTEMPE, Ariz.–(BUSINESS WIRE)–INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, to
Read moreKraig Biocraft Laboratories have named a new member to its expanded Board of Directors, who will be joining the company as an independent director.
Read moreSAN DIEGO–(BUSINESS WIRE)–#Biocom–Biocom, the association representing the life science industry of California, issued the following statement in response to a
Read moreCerevel Therapeutics is expecting to presented data from studying Tavapadon in patients with early-stage Parkinson’s Disease, at the 2019 International
Read moreSan Francisco based clinical-stage biotech company Five Prime Therapeutics has named the new interim Chief Executive Officer, William Ringo, who will start immediately, to replace Aron Knickerbocker, who has resigned to look for new opportunities.
Read more